Category Archives: Pr Newswire

Adagene Announces Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at Upcoming European Society for Medical Oncology (ESMO) Congress in September

SAN DIEGO and SUZHOU, China, July 12, 2024 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced a poster presentation at the upcoming ESMO Congress, taking place in Barcelona, Spain, 13-17 September 2024. The poster will report results of an ongoing phase 1b/2 […]

Singapore’s First-Ever Convention on New Launch Condominiums Sells 1,114 Tickets, Analysing A Record 80 Projects Under One Roof

SINGAPORE, July 12, 2024 /PRNewswire/ — Almost 1,000 new condo enthusiasts thronged Suntec Convention Centre for an industry analysis of over 80 of Singapore’s past and upcoming new launch condominiums. A first-of-its-kind cross-industry collaboration between PropertyLimBrothers Media, personal finance platform Seedly, and event partner Unearthed Productions, the New Launch Convention 2024 was a timely showcase […]

Yiren Digital’s First ESG Report Highlights at a Glance

BEIJING, July 12, 2024 /PRNewswire/ — Yiren Digital Ltd. (NYSE: YRD), an AI-powered platform providing financial and lifestyle services in China, recently released its first ESG report. The report underscores Yiren Digital’s mission of “Better Lives Through Digital Innovation,” highlighting its commitment to environmental sustainability and social responsibility. Here are the highlights at a glance. […]

Senhwa Biosciences Clinical Data Abstract of Pidnarulex Accepted for Presentation at 2024 ESMO Congress

TAIPEI and SAN DIEGO, July 12, 2024 /PRNewswire/ — Senhwa Biosciences’ new drug Pidnarulex (CX-5461) has demonstrated efficacy in treating various solid tumors with BRCA2 or PALB2 gene defects. The abstract of this clinical trial has been selected for presentation at the 2024 European Society for Medical Oncology (ESMO) congress. This achievement is a significant […]

foodpanda reaffirms commitment to enhance delivery partners’ work experience with ‘panda hearts’

Flagship programme doubles down on five aspects of platform work that foodpanda’s delivery partners value KUALA LUMPUR, Malaysia and BANGKOK, July 12, 2024 /PRNewswire/ — Leading food and grocery delivery platform foodpanda is doubling down on its commitment to its delivery partners with ‘panda hearts’, its flagship programme aimed at uplifting and supporting delivery partners in five […]

HIGHWAY HOLDINGS RESTATES UNAUDITED FINANCIAL STATEMENTS FOR 3 AND 9 MONTHS ENDED DECEMBER 31, 2023 RESULTING IN HIGHER NET INCOME FOR BOTH PERIODS

HONG KONG, July 12, 2024 /PRNewswire/ — Highway Holdings Limited (Nasdaq: HIHO) (the “Company” or “Highway Holdings”) today announced it has restated its unaudited quarterly financial statements for the three and nine months ended December 31, 2023, which were released in an earnings press release on February 1, 2024. The decision to restate the financial […]

Immutep Reports Positive Results in First Line Head and Neck Squamous Cell Carcinoma Patients with Negative PD-L1 Expression

Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST 1.1, among the highest recorded for a treatment approach not containing chemotherapy in patients with CPS <1 High complete response rate of 9.7% with three patients showing a disappearance of cancer lesions post treatment Durability […]

Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting

Protective Effects of ANX007 on Visual Acuity and Vision Related Anatomical Measures in the Central Macula Will be Presented as a Late-Breaking Oral Presentation Topline Phase 2 ARCHER Trial Results Will be Discussed as an Oral Presentation BRISBANE, Calif., July 11, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel therapies […]

Teladoc Health Is Providing Free Virtual Health Care Services to Texas Residents Impacted by Hurricane Beryl

PURCHASE, N.Y., July 11, 2024 (GLOBE NEWSWIRE) —  Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to Texas residents, first responders and others directly impacted by Hurricane Beryl. Individuals in Texas who have been displaced or who cannot access medical care as a result […]

Shineco Announces Proposed Underwritten Public Offering

Beijing, July 11, 2024 (GLOBE NEWSWIRE) — Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced it has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase its shares of common stock. All of the shares […]